Perspective Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Perspective Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q2 2024.
  • Perspective Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$14.3M, a 46.2% decline year-over-year.
  • Perspective Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$48.7M, a 97.1% decline year-over-year.
  • Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$40.9M, a 372% decline from 2022.
  • Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$8.67M, a 152% decline from 2021.
  • Perspective Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$3.45M, a 0.86% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$48.7M -$14.3M -$4.51M -46.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$44.2M -$13M -$3.24M -33.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$40.9M -$10.9M -$9.91M -1009% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$31M -$10.5M -$6.33M -150% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$24.7M -$9.75M -$7.65M -363% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$17.1M -$9.76M -$8.39M -609% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$8.67M -$982K +$653K +39.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$9.33M -$4.21M -$1.93M -85% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.39M -$2.11M -$1.01M -92.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$6.38M -$1.38M -$610K -79.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$5.77M -$1.64M -$762K -87.3% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-09
Q3 2021 -$5.01M -$2.27M -$1.56M -218% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.45M -$1.09M +$96K +8.07% Apr 1, 2021 Jun 30, 2021 10-KT 2023-05-01
Q1 2021 -$3.54M -$766K -$218K -39.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$3.32M -$873K +$30K +3.32% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$3.35M -$714K +$122K +14.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.48M -$1.19M -$45K -3.93% Apr 1, 2020 Jun 30, 2020 10-KT 2023-05-01
Q1 2020 -$3.43M -$548K +$615K +52.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$4.05M -$903K +$526K +36.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$4.57M -$836K +$682K +44.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$5.25M -$1.14M +$1.23M +51.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-09-27
Q1 2019 -$6.48M -$1.16M +$176K +13.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$6.66M -$1.43M +$39K +2.66% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 -$6.7M -$1.52M +$34K +2.19% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$6.73M -$2.37M -$506K -27.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-09-25
Q1 2018 -$6.22M -$1.34M +$50K +3.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$6.27M -$1.47M +$11K +0.74% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 -$6.28M -$1.55M +$23K +1.46% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$6.31M -$1.86M -$610K -48.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-09-27
Q1 2017 -$5.7M -$1.39M -$62K -4.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$5.64M -$1.48M -$69K -4.89% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 -$5.57M -$1.58M -$484K -44.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$5.08M -$1.25M -$149K -13.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-09-26
Q1 2016 -$4.93M -$1.33M -$276K -26.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$4.66M -$1.41M -$390K -38.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 -$4.27M -$1.09M +$70.1K +6.04% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.34M -$1.1M +$216K +16.3% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-28
Q1 2015 -$4.55M -$1.05M -$62K -6.27% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$4.49M -$1.02M +$24.1K +2.3% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$4.51M -$1.16M +$73.4K +5.95% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$4.59M -$1.32M -$299K -29.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-09
Q1 2014 -$4.29M -$989K -$165K -20% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$4.12M -$1.04M +$55.1K +5.01% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$4.18M -$1.23M -$112K -9.95% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$4.07M -$1.02M -$80.1K -8.52% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-14
Q1 2013 -$3.99M -$824K -$61.3K -8.03% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$3.93M -$1.1M -$307K -38.8% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$3.62M -$1.12M -$20.5K -1.86% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$3.6M -$941K -$174K -22.7% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 -$3.42M -$763K -$69.4K -10% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$3.35M -$792K -$157K -24.8% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$3.2M -$1.1M -$234K -26.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$2.96M -$766K Apr 1, 2011 Jun 30, 2011 10-K/A 2012-10-26
Q1 2011 -$693K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$635K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$868K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.